David Nieuwsma

David Nieuwsma Joins Kopin Corporation Board of Directors

November 07, 2023 08:30 AM Eastern Standard Time WESTBOROUGH, Mass.–(BUSINESS WIRE)–Kopin Corporation (NASDAQ: KOPN), a leading provider of application specific optical systems and high performance micro-displays for defense, enterprise, consumer and medical products, today announced David Nieuwsma has joined Kopin Corporation’s Board of Directors. “David has extensive operational experience, credibility and is a trusted leader in the defense industry, our primary revenue market. We look forward … Continue reading David Nieuwsma Joins Kopin Corporation Board of Directors

ELUCID

Elucid Raises $80 Million in Series C Round Led by Elevage Medical Technologies

Investment will drive commercialization and expansion of AI-powered non-invasive diagnostic tools to help evaluate cardiovascular risk November 09, 2023 07:05 AM Eastern Standard Time BOSTON–(BUSINESS WIRE)–Elucid, a leading medical technology company providing physicians with AI-powered imaging analysis software to assess cardiovascular disease, today announced it has raised $80 million in Series C funding. The round was led by Elevage Medical Technologies, with additional participation from industry … Continue reading Elucid Raises $80 Million in Series C Round Led by Elevage Medical Technologies

DAIICHI SANKYO EUROPE

Change in Leadership at Daiichi Sankyo Europe

Masahiro Kato takes over as Managing Director, Oliver Appelhans appointed to Head of the European Specialty Business Unit November 06, 2023 02:00 AM Eastern Standard Time MUNICH–(BUSINESS WIRE)–Today, Daiichi Sankyo Europe GmbH, the European headquarter organisation of the Japanese pharmaceutical company Daiichi Sankyo Co., Ltd., announced the appointment of its new Managing Director Masahiro Kato and new Head of the European Speciality Business Unit, Oliver … Continue reading Change in Leadership at Daiichi Sankyo Europe

Tandem Diabetes Care

Tandem Diabetes Care Appoints Mark Novara as EVP and Chief Commercial Officer

November 01, 2023 04:06 PM Eastern Daylight Time SAN DIEGO–(BUSINESS WIRE)–Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced the appointment of Mark Novara as Executive Vice President and Chief Commercial Officer, effective November 13, 2023. Mr. Novara comes to Tandem with extensive global healthcare experience, having served in the diabetes, medical technology, and life sciences industries for … Continue reading Tandem Diabetes Care Appoints Mark Novara as EVP and Chief Commercial Officer

PHARMAJET

Daicel Group Invests in PharmaJet

October 31, 2023 11:10 AM Eastern Daylight Time GOLDEN, Colo.–(BUSINESS WIRE)–PharmaJet®, a company that engineers precision delivery systems that overcome the challenges of vaccines and pharmaceuticals delivery, today announced that it received a strategic investment from the Daicel Corporation. This investment coincides with Daicel’s announcement of the establishment of a new company, Daicel Medical Ltd., and reinforces Daicel’s commitment to growth in this critical area of … Continue reading Daicel Group Invests in PharmaJet

UPWARD HEALTH

Upward Health Announces Appointment of New Chief Financial Officer

October 25, 2023 10:00 AM Eastern Daylight Time HAUPPAUGE, N.Y.–(BUSINESS WIRE)–Upward Health, a risk-bearing, in-home medical group, today announced the appointment of Benjamin Hamawy to Chief Financial Officer.   “The opportunity for value creation is tremendous given the talent, drive, and passion of the team. I am confident that together we can develop and implement financial strategies to further support Upward Health’s expansion plans.”Tweet this … Continue reading Upward Health Announces Appointment of New Chief Financial Officer

LEO PHARMA

Globally Known Professor and Dermatologist Joins LEO Pharma

Ahead of EADV, LEO Pharma announces that Professor Alexander Egeberg, a board-certified dermatologist, and top key opinion leader, will join the company as Head of Global Medical Affairs. October 09, 2023 04:00 AM Eastern Daylight Time BALLERUP, Denmark – LEO Pharma A/S, a global leader in medical dermatology, is today announcing the appointment of Professor Alexander Egeberg, a globally recognized dermatologist and top key opinion … Continue reading Globally Known Professor and Dermatologist Joins LEO Pharma

LIVANOVA

LivaNova Board Appoints J. Christopher Barry as New Director

Long-time Director Andrea Saia to retire from the Board October 06, 2023 08:30 AM Eastern Daylight Time LONDON – LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, announced its Board of Directors has appointed J. Christopher Barry to the Board, effective today. Barry will serve on the Audit and Compliance Committee. Andrea Saia, who has served as a Director since 2016, will retire from … Continue reading LivaNova Board Appoints J. Christopher Barry as New Director